Li, Linna <br/><br/>
A Phase II study of anti-epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme.  [electronic resource] 

 -  Journal of neurosurgery  Aug 2010 
 - 192-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1933-0693 
<br/><br/><label>Standard No.: </label>10.3171/2010.2.JNS091211  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Antineoplastic Agents, Alkylating--therapeutic use<br/>Brain Neoplasms--drug therapy<br/>Combined Modality Therapy<br/>Dacarbazine--analogs & derivatives<br/>ErbB Receptors--immunology<br/>Female<br/>Glioblastoma--drug therapy<br/>Humans<br/>Iodine Radioisotopes--administration & dosage<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Proportional Hazards Models<br/>Prospective Studies<br/>Radioimmunotherapy--adverse effects<br/>Radiotherapy, Adjuvant--adverse effects<br/>Temozolomide<br/>Young Adult